TuisGUD • TSE
add
Knight Therapeutics Inc
Vorige sluiting
$5,55
Dagwisseling
$5,53 - $5,73
Jaarwisseling
$5,09 - $6,23
Markkapitalisasie
567,27 m CAD
Gemiddelde volume
61,29 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
TSE
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CAD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 92,26 m | 13,21% |
Bedryfskoste | 41,81 m | 6,53% |
Netto inkomste | 85,00 k | -99,11% |
Netto winsgrens | 0,09 | -99,23% |
Wins per aandeel | — | — |
EBITDA | 16,59 m | 13,43% |
Effektiewe belastingkoers | 86,02% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CAD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 172,32 m | 7,75% |
Totale bates | 962,29 m | -4,83% |
Totale aanspreeklikheid | 188,38 m | -4,12% |
Totale ekwiteit | 773,91 m | — |
Uitstaande aandele | 100,80 m | — |
Prys om te bespreek | 0,72 | — |
Opbrengs op bates | 0,84% | — |
Opbrengs op kapitaal | 0,97% | — |
Kontantvloei
Netto kontantverandering
| (CAD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 85,00 k | -99,11% |
Kontant van bedrywe | 5,02 m | -66,93% |
Kontant van beleggings | 11,53 m | -67,76% |
Kontant van finansiering | -3,93 m | 65,06% |
Netto kontantverandering | 12,95 m | -67,28% |
Beskikbare kontantvloei | 1,02 m | 121,60% |
Meer oor
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Gestig
2014
Hoofkwartier
Webwerf
Werknemers
725
